This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center, Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 60 
1 out of 915 
Years Active: 2010
Title: Chava Perry: Innovator in Hematopoietic Cell Differentiation
Introduction
Chava Perry is a notable inventor based in Ramat Gan, Israel. He has made significant contributions to the field of hematopoietic cell differentiation through his innovative research and patents. His work focuses on the use of peptides to induce granulocytopoiesis, which has important implications for medical treatments.
Latest Patents
Chava Perry holds a patent titled "Acetylcholinesterase (ACHE)-derived peptide as an inducer of granulocytopoiesis, uses and methods thereof." This invention describes the use of an AChE-R-derived peptide, also known as ARP, as an inducer of hemopoietic cell differentiation and expansion, specifically for the granulocytic population. The patent also presents the use of ARP as an inducer of thrombopoietin and pro-inflammatory cytokines. Furthermore, ARP may be utilized in the pre-transplant priming of hematopoietic stem cells, showcasing its potential in various medical applications.
Career Highlights
Throughout his career, Chava Perry has worked with esteemed organizations such as Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and the Medical Research Fund at the Tel Aviv Sourasky Medical Center. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Chava Perry has collaborated with notable colleagues, including Hermona Soreq and Dan Grisaru. These partnerships have enriched his research and expanded the impact of his work in the field of hematopoietic cell differentiation.
Conclusion
Chava Perry's innovative work in the development of peptides for granulocytopoiesis represents a significant advancement in medical research. His contributions through patents and collaborations highlight the importance of innovation in the field of hematology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile